Aytu BioScience
AYTU
#10768
Rank
C$27.6 M
Marketcap
C$2.54
Share price
-0.56%
Change (1 day)
-8.50%
Change (1 year)

P/E ratio for Aytu BioScience (AYTU)

P/E ratio as of November 2026 (TTM): -1.30

According to Aytu BioScience 's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -1.29927. At the end of 2023 the company had a P/E ratio of -0.7030.

P/E ratio history for Aytu BioScience from 2008 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2023-0.7030790.37%
2022-0.0790-78.1%
2021-0.3605-82.7%
2020-2.08
2017-0.169336.77%
2016-0.1238-92.25%
2015-1.60

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Rollins
ROL
35.7-2,845.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Stride (K12 Education)
LRN
9.60-838.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Cullinan Therapeutics
CGEM
-3.32 155.23%๐Ÿ‡บ๐Ÿ‡ธ USA

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.